Clinical evaluation of molecular detection for sentinel lymph node examination in breast cancer patients
Not Applicable
- Conditions
- Primary breast cancer
- Registration Number
- JPRN-UMIN000005321
- Lead Sponsor
- Japanese Study Group of the OSNA assay
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 450
Inclusion Criteria
Not provided
Exclusion Criteria
Patients without their consent. Patients who underwent primary systemic chemotherapy or primasy systemic hormonal therapy before sentinel lymph node biopsy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method